BVF PARTNERS L P/IL Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Latest Insider Trading Transactions of BVF PARTNERS L P/IL

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page: 1 2 3 4 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 26 2021	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	J	0.00	99,556	0	99,556	0 to 99.6 K
May 17 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	P	14.26	3,474	49,544	91,700	88.2 K to 91.7 K (+3.94 %)
May 17 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	P	14.26	22,721	324,036	555,105	532.4 K to 555.1 K (+4.27 %)
May 17 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	P	14.26	31,805	453,587	761,537	729.7 K to 761.5 K (+4.36 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	134,515	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	152,176	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	17,390	0	152,176
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	837,397	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	553,359	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	84,350	0	553,359
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,068,554	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	832,261	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	115,293	0	832,261
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	134,515	0	286,691	152.2 K to 286.7 K (+88.39 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	152,176	0	152,176	0 to 152.2 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	1,747	26,032	88,226	86.5 K to 88.2 K (+2.02 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	6,141	97,817	86,479	80.3 K to 86.5 K (+7.64 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	62,948	1,070,116	80,338	17.4 K to 80.3 K (+361.98 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	17,390	0	17,390	0 to 17.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	837,397	0	1,390,756	553.4 K to 1.4 M (+151.33 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	553,359	0	553,359	0 to 553.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	10,876	162,062	532,384	521.5 K to 532.4 K (+2.09 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	38,858	618,950	521,508	482.7 K to 521.5 K (+8.05 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	398,300	6,771,100	482,650	84.4 K to 482.7 K (+472.20 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	134,515	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	84,350	0	84,350	0 to 84.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	152,176	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	1,068,554	0	1,900,815	832.3 K to 1.9 M (+128.39 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	17,390	0	152,176
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	832,261	0	832,261	0 to 832.3 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	837,397	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	14,790	220,384	729,732	714.9 K to 729.7 K (+2.07 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	553,359	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	53,303	849,037	714,942	661.6 K to 714.9 K (+8.06 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	84,350	0	553,359
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	546,346	9,287,882	661,639	115.3 K to 661.6 K (+473.88 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,068,554	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	115,293	0	115,293	0 to 115.3 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	832,261	0	0
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	115,293	0	832,261
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	134,515	0	286,691	152.2 K to 286.7 K (+88.39 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	152,176	0	152,176	0 to 152.2 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	1,747	26,032	88,226	86.5 K to 88.2 K (+2.02 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	6,141	97,817	86,479	80.3 K to 86.5 K (+7.64 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	62,948	1,070,116	80,338	17.4 K to 80.3 K (+361.98 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	17,390	0	17,390	0 to 17.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	837,397	0	1,390,756	553.4 K to 1.4 M (+151.33 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	553,359	0	553,359	0 to 553.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	10,876	162,062	532,384	521.5 K to 532.4 K (+2.09 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	38,858	618,950	521,508	482.7 K to 521.5 K (+8.05 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	398,300	6,771,100	482,650	84.4 K to 482.7 K (+472.20 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	84,350	0	84,350	0 to 84.4 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	1,068,554	0	1,900,815	832.3 K to 1.9 M (+128.39 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	832,261	0	832,261	0 to 832.3 K
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	14.90	14,790	220,384	729,732	714.9 K to 729.7 K (+2.07 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	15.93	53,303	849,037	714,942	661.6 K to 714.9 K (+8.06 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Grant	A	17.00	546,346	9,287,882	661,639	115.3 K to 661.6 K (+473.88 %)
Apr 27 2021	RAIN	Rain Therapeutics ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	115,293	0	115,293	0 to 115.3 K
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Option Exercise	P	0.00	17	0	17
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Option Exercise	P	0.00	239	0	239
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Option Exercise	P	0.00	344	0	344
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Buy	P	2.50	5,171	12,928	488,879	483.7 K to 488.9 K (+1.07 %)
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Buy	P	2.50	950,016	2,375,040	3,059,296	2.1 M to 3.1 M (+45.04 %)
Apr 05 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Buy	P	2.50	1,044,813	2,612,033	4,085,933	3 M to 4.1 M (+34.36 %)
Apr 01 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.75	26,894	531,157	462,015	435.1 K to 462 K (+6.18 %)
Apr 01 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.75	108,106	2,135,094	2,892,385	2.8 M to 2.9 M (+3.88 %)
Apr 01 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	19.75	165,000	3,258,750	3,803,152	3.6 M to 3.8 M (+4.54 %)
Mar 24 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	22.75	7,744	176,176	435,121	427.4 K to 435.1 K (+1.81 %)
Mar 24 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	22.75	71,756	1,632,449	3,638,152	3.6 M to 3.6 M (+2.01 %)
Mar 18 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	23.00	1,171	26,933	427,377	426.2 K to 427.4 K (+0.27 %)
Mar 18 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	23.00	195,768	4,502,586	2,784,279	2.6 M to 2.8 M (+7.56 %)
Mar 18 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	23.00	53,061	1,220,382	3,566,396	3.5 M to 3.6 M (+1.51 %)
Mar 12 2021	CTIC	CTI BIOPHARMA CORP	BVF PARTNERS L P/IL	Director	Option Exercise	A	3.30	80,000	264,000	80,000
Feb 04 2021	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL		Sell	S	18.00	4,325	77,850	233,150	237.5 K to 233.2 K (-1.82 %)
Feb 04 2021	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL		Sell	S	18.00	16,850	303,300	1,188,131	1.2 M to 1.2 M (-1.40 %)
Feb 04 2021	IDYA	IDEAYA Biosciences ...	BVF PARTNERS L P/IL		Sell	S	18.00	25,234	454,212	1,642,186	1.7 M to 1.6 M (-1.51 %)
Jan 26 2021	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	4.14	568,019	2,350,917	686,974	1.3 M to 687 K (-45.26 %)
Jan 26 2021	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	4.14	2,458,838	10,176,639	4,172,298	6.6 M to 4.2 M (-37.08 %)
Jan 26 2021	INFI	INFINITY PHARMACEU ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	4.14	2,821,663	11,678,299	5,663,912	8.5 M to 5.7 M (-33.25 %)
Jan 25 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	24.75	43,422	1,074,695	426,206	382.8 K to 426.2 K (+11.34 %)
Jan 25 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	24.75	343,444	8,500,239	2,588,511	2.2 M to 2.6 M (+15.30 %)
Jan 25 2021	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	24.75	457,814	11,330,897	3,513,335	3.1 M to 3.5 M (+14.98 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	1,757	0	6,758
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	9,169	0	39,693
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	11,776	0	52,145
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	35	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	203	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Option Exercise	C	0.00	273	0	0
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	97,615	0	113,152	15.5 K to 113.2 K (+628.27 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	1,944	0	15,537	13.6 K to 15.5 K (+14.30 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	509,410	0	598,624	89.2 K to 598.6 K (+571.00 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	11,278	0	89,214	77.9 K to 89.2 K (+14.47 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	654,215	0	771,780	117.6 K to 771.8 K (+556.47 %)
Dec 28 2020	NVUS	Eledon Pharmaceuti ...	BVF PARTNERS L P/IL		Buy	C	0.00	15,166	0	117,565	102.4 K to 117.6 K (+14.81 %)
Dec 22 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	16.05	45,032	722,764	2,245,067	2.2 M to 2.2 M (+2.05 %)
Dec 22 2020	MRUS	Merus N.V.	BVF PARTNERS L P/IL	10% Owner	Buy	P	16.05	114,968	1,845,236	3,055,521	2.9 M to 3.1 M (+3.91 %)
Dec 15 2020	XOMA	XOMA Corp	BVF PARTNERS L P/IL	Director	Buy	P	25.00	200,000	5,000,000	200,000	0 to 200 K
Dec 11 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Sell	S	18.00	25,486	458,748	463,244	488.7 K to 463.2 K (-5.21 %)
Dec 11 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Sell	S	18.00	166,194	2,991,492	2,760,185	2.9 M to 2.8 M (-5.68 %)
Dec 11 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Sell	S	18.00	239,274	4,306,932	3,811,271	4.1 M to 3.8 M (-5.91 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	73,399	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	522,403	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	760,155	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	101,784	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	673,281	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	889,186	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	185,908	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	881,156	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,129,404	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	74,991	1,424,829	436,082	361.1 K to 436.1 K (+20.77 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	73,399	0	361,091	287.7 K to 361.1 K (+25.51 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	101,784	0	287,692	185.9 K to 287.7 K (+54.75 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	185,908	0	185,908	0 to 185.9 K
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	446,425	8,482,075	2,523,265	2.1 M to 2.5 M (+21.50 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	73,399	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	522,403	0	2,076,840	1.6 M to 2.1 M (+33.61 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	522,403	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	673,281	0	1,554,437	881.2 K to 1.6 M (+76.41 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	760,155	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	881,156	0	881,156	0 to 881.2 K
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	101,784	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	613,918	11,664,442	3,392,663	2.8 M to 3.4 M (+22.09 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	673,281	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	760,155	0	2,778,745	2 M to 2.8 M (+37.66 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	889,186	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	889,186	0	2,018,590	1.1 M to 2 M (+78.73 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	185,908	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	1,129,404	0	1,129,404	0 to 1.1 M
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	881,156	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	C	0.00	1,129,404	0	0
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Option Exercise	A	19.00	21,520	408,880	21,520
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	74,991	1,424,829	436,082	361.1 K to 436.1 K (+20.77 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	73,399	0	361,091	287.7 K to 361.1 K (+25.51 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	101,784	0	287,692	185.9 K to 287.7 K (+54.75 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	185,908	0	185,908	0 to 185.9 K
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	446,425	8,482,075	2,523,265	2.1 M to 2.5 M (+21.50 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	522,403	0	2,076,840	1.6 M to 2.1 M (+33.61 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	673,281	0	1,554,437	881.2 K to 1.6 M (+76.41 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	881,156	0	881,156	0 to 881.2 K
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	P	19.00	613,918	11,664,442	3,392,663	2.8 M to 3.4 M (+22.09 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	760,155	0	2,778,745	2 M to 2.8 M (+37.66 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	889,186	0	2,018,590	1.1 M to 2 M (+78.73 %)
Nov 20 2020	OLMA	Olema Pharmaceutic ...	BVF PARTNERS L P/IL	Director	Buy	C	0.00	1,129,404	0	1,129,404	0 to 1.1 M
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	93	1,860	0
Nov 20 2020	CYTK	CYTOKINETICS INC	BVF PARTNERS L P/IL		Option Exercise	J	20.00	551	11,020	0

Page: 1 2 3 4 4 next >